The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Anthracycline Cardiotoxicity: From Bench to Bedside
Open accessAbstract
Anthracyclines remain among the most widely prescribed and effective anticancer agents. Unfortunately, life-threatening cardiotoxicity continues to compromise their usefulness. Despite more than four decades of investigation, the pathogenic mechanisms responsible for anthracycline cardiotoxicity have not been completely elucidated. In addition, new drugs and combination therapies often exacerbate the toxicity. The First International Workshop on Anthracycline Cardiotoxicity, held in fall 2006, in Como, Italy, focused on the state-of-the-art knowledge and discussed the research needed to address the cardiotoxicity of these drugs. Here, we incorporate these discussions into the framework of a broader review of preclinical and clinical issues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 1×
“first clue to the importance of paracrine growth and survival factors in anthracycline-induced cardiac dysfunction.(48) Since that observation, the impairment of tyrosine kinase–mediated signaling pathways has been studied, both in vitro and in vivo.”
BackgroundJemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Self-citationChronic Health Conditions in Adult Survivors of Childhood Cancer
Oeffinger, K. C., Mertens, A. C., Sklar, C. A., Kawashima, T., Hudson, M. M., Meadows, A. T., Friedman, D. L., Marina, N., Hobbie, W., Kadan-Lottick, N. S., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmsa060185 · Cited by 3,597
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages
Laugwitz, K.-L., Moretti, A., Lam, J., Gruber, P., Chen, Y., Woodard, S., Lin, L.-Z., Cai, C.-L., Lu, M. M., Reth, M., et al. (2005) · Nature · doi:10.1038/nature03215 · Cited by 1,304
Lamon, D. E. J. S., Eyland, B. R. L., Hak, S. T. S., Uchs, H. A. F., Aton, V. I. P., Ajamonde, A. L. B., LeMing, T., Iermann, W. O. E., Olter, J. A. W., Egram, M. A. P., et al. (2009) · Cited by 1,199
Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis
McNeely, M. L. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051073 · Cited by 1,078
Cardinale, D., Sandri, M. T., Colombo, A., Colombo, N., Boeri, M., Lamantia, G., Civelli, M., Peccatori, F., Martinelli, G., Fiorentini, C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130926.51766.cc · Cited by 955
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition
Force, T., Krause, D. S., & Van Etten, R. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2106 · Cited by 801
Mertens, A. C., Yasui, Y., Neglia, J. P., Potter, J. D., Nesbit, M. E., Ruccione, K., Smithson, W. A., & Robison, L. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3163 · Cited by 798
Carver, J. R., Shapiro, C. L., Ng, A., Jacobs, L., Schwartz, C., Virgo, K. S., Hagerty, K. L., Somerfield, M. R., & Vaughn, D. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.9777 · Cited by 793
Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Dalton, V. M., Mone, S. M., Gelber, R. D., & Colan, S. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.121 · Cited by 727
Self-citationProtective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Landier, W., Bhatia, S., Eshelman, D. A., Forte, K. J., Sweeney, T., Hester, A. L., Darling, J., Armstrong, F. D., Blatt, J., Constine, L. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.032 · Cited by 706
Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity
Ewer, M. S., & Lippman, S. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.827 · Cited by 646
Pinder, M. C., Duan, Z., Goodwin, J. S., Hortobagyi, G. N., & Giordano, S. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4976 · Cited by 634
Lyu, Y. L., Kerrigan, J. E., Lin, C.-P., Azarova, A. M., Tsai, Y.-C., Ban, Y., & Liu, L. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1649 · Cited by 612
Yu, C.-M., Sanderson, J. E., Marwick, T. H., & Oh, J. K. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.078 · Cited by 571
Trastuzumab-Associated Cardiac Adverse Effects in the Herceptin Adjuvant Trial
Suter, T. M., Procter, M., van Veldhuisen, D. J., Muscholl, M., Bergh, J., Carlomagno, C., Perren, T., Passalacqua, R., Bighin, C., Klijn, J. G. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1611 · Cited by 566
Krischer, J. P., Epstein, S., Cuthbertson, D. D., Goorin, A. M., Epstein, M. L., & Lipshultz, S. E. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.4.1544 · Cited by 476
Self-citationUGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters
Hoskins, J. M., Goldberg, R. M., Qu, P., Ibrahim, J. G., & McLeod, H. L. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm115 · Cited by 469
Wouters, K. A., Kremer, L. C. M., Miller, T. L., Herman, E. H., & Lipshultz, S. E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05759.x · Cited by 453
Self-citationEarly Breast Cancer Therapy and Cardiovascular Injury
Jones, L. W., Haykowsky, M. J., Swartz, J. J., Douglas, P. S., & Mackey, J. R. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.037 · Cited by 447
Trastuzumab-Related Cardiotoxicity: Calling Into Question the Concept of Reversibility
Telli, M. L., Hunt, S. A., Carlson, R. W., & Guardino, A. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.0106 · Cited by 385
Predictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial Injury
Lipshultz, S. E., Rifai, N., Sallan, S. E., Lipsitz, S. R., Dalton, V., Sacks, D. B., & Ottlinger, M. E. (1997) · Circulation · doi:10.1161/01.cir.96.8.2641 · Cited by 384
Self-citationAnthracycline associated cardiotoxicity in survivors of childhood cancer
Lipshultz, S. E., Alvarez, J. A., & Scully, R. E. (2008) · Heart · doi:10.1136/hrt.2007.136093 · Cited by 379
Self-citationSpeyer, J. L., Green, M. D., Kramer, E., Rey, M., Sanger, J., Ward, C., Dubin, N., Ferrans, V., Stecy, P., Zeleniuch-Jacquotte, A., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809223191203 · Cited by 356
Fisher, P. W., Salloum, F., Das, A., Hyder, H., & Kukreja, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000160359.49478.c2 · Cited by 355
Subclinical Late Cardiomyopathy After Doxorubicin Therapy for Lymphoma in Adults
Hequet, O., Le, Q. H., Moullet, I., Pauli, E., Salles, G., Espinouse, D., Dumontet, C., Thieblemont, C., Arnaud, P., Antal, D., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.033 · Cited by 340
Chemotherapy and Cardiotoxicity in Older Breast Cancer Patients: A Population-Based Study
Doyle, J. J., Neugut, A. I., Jacobson, J. S., Grann, V. R., & Hershman, D. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.5841 · Cited by 335
Green, D. M., Grigoriev, Y. A., Nan, B., Takashima, J. R., Norkool, P. A., D’Angio, G. J., & Breslow, N. E. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.7.1926 · Cited by 319
Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Simbre, V. C., Shaikh, S. L., Mone, S. M., Gelber, R. D., & Colan, S. D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.102 · Cited by 308
Self-citationAnthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management
Barry, E., Alvarez, J. A., Scully, R. E., Miller, T. L., & Lipshultz, S. E. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.8.1039 · Cited by 307
Self-citationAnthracyclines Induce Calpain-dependent Titin Proteolysis and Necrosis in Cardiomyocytes
Lim, C. C., Zuppinger, C., Guo, X., Kuster, G. M., Helmes, M., Eppenberger, H. M., Suter, T. M., Liao, R., & Sawyer, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308033200 · Cited by 304
Self-citationSilber, J. H., Cnaan, A., Clark, B. J., Paridon, S. M., Chin, A. J., Rychik, J., Hogarty, A. N., Cohen, M. I., Barber, G., Rutkowski, M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.022 · Cited by 299
Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity
Aries, A., Paradis, P., Lefebvre, C., Schwartz, R. J., & Nemer, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401833101 · Cited by 296
Role of anthracyclines in the era of targeted therapy
Cortés-Funes, H., & Coronado, C. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0015-3 · Cited by 294
Probucol Protects Against Adriamycin Cardiomyopathy Without Interfering With Its Antitumor Effect
Siveski-Iliskovic, N., Hill, M., Chow, D. A., & Singal, P. K. (1995) · Circulation · doi:10.1161/01.cir.91.1.10 · Cited by 285
Liu, X., Gu, X., Li, Z., Li, X., Li, H., Chang, J., Chen, P., Jin, J., Xi, B., Chen, D., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.057 · Cited by 274
Schuchter, L. M., Hensley, M. L., Meropol, N. J., & Winer, E. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.178 · Cited by 262
Antioxidants and Cancer Therapy: A Systematic Review
Ladas, E. J., Jacobson, J. S., Kennedy, D. D., Teel, K., Fleischauer, A., & Kelly, K. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.086 · Cited by 260
Möller, T. R., Garwicz, S., Barlow, L., Winther, J. F., Glattre, E., Olafsdottir, G., Olsen, J. H., Perfekt, R., Ritvanen, A., Sankila, R., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3173 · Cited by 259
Sandri, M. T., Salvatici, M., Cardinale, D., Zorzino, L., Passerini, R., Lentati, P., Leon, M., Civelli, M., Martinelli, G., & Cipolla, C. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.050153 · Cited by 250
Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions
Wang, L., & Weinshilboum, R. (2006) · Oncogene · doi:10.1038/sj.onc.1209372 · Cited by 225
Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis
Wallace, K. B. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0008-2 · Cited by 221
Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic
Arcamone, F., Franceschi, G., Penco, S., & Selva, A. (1969) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)97723-8 · Cited by 220
Lebrecht, D., Setzer, B., Ketelsen, U.-P., Haberstroh, J., & Walker, U. A. (2003) · Circulation · doi:10.1161/01.cir.0000093196.59829.df · Cited by 219
TASSANMANGINA, S., CODOREAN, D., METIVIER, M., COSTA, B., HIMBERLIN, C., JOUANNAUD, C., BLAISE, A., ELAERTS, J., & NAZEYROLLAS, P. (2006) · European Journal of Echocardiography · doi:10.1016/j.euje.2005.04.009 · Cited by 213
DNA damage is an early event in doxorubicin-induced cardiac myocyte death
L'Ecuyer, T., Sanjeev, S., Thomas, R., Novak, R., Das, L., Campbell, W., & Heide, R. V. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00738.2005 · Cited by 212
Herman, E. H., Zhang, J., Lipshultz, S. E., Rifai, N., Chadwick, D., Takeda, K., Yu, Z.-X., & Ferrans, V. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2237 · Cited by 210
Self-citationLeft Ventricular Ejection Fraction and Cardiotoxicity: Is Our Ear Really to the Ground?
Ewer, M. S., & Lenihan, D. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.8742 · Cited by 207
Fürstenberger, G., von Moos, R., Lucas, R., Thürlimann, B., Senn, H.-J., Hamacher, J., & Boneberg, E.-M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602952 · Cited by 205
Marty, M., Espié, M., Llombart, A., Monnier, A., Rapoport, B. L., & Stahalova, V. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj134 · Cited by 202
The "Final Common Pathway" Hypothesis and Inherited Cardiovascular Disease
Bowles, N. E., Bowles, K. R., & Towbin, J. A. (2000) · Herz · doi:10.1007/s000590050003 · Cited by 197
Ganame, J., Claus, P., Uyttebroeck, A., Renard, M., D’hooge, J., Bijnens, B., Sutherland, G. R., Eyskens, B., & Mertens, L. (2007) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.04.007 · Cited by 194
Role of Neuregulin-1/ErbB2 Signaling in Endothelium-Cardiomyocyte Cross-talk
Lemmens, K., Segers, V. F. M., Demolder, M., & De Keulenaer, G. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600399200 · Cited by 192
Chronic Health Conditions in Adult Survivors of Childhood Cancer
Oeffinger, K. C., Mertens, A. C., & Sklar, C. A. (2007) · Oncology Times · doi:10.1097/01.cot.0000265629.30194.8e · Cited by 187
Zambetti, M., Moliterni, A., Materazzo, C., Stefanelli, M., Cipriani, S., Valagussa, P., Bonadonna, G., & Gianni, L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.37 · Cited by 186
Self-citationTimolati, F., Ott, D., Pentassuglia, L., Giraud, M.-N., Perriard, J.-C., Suter, T. M., & Zuppinger, C. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.08.002 · Cited by 178
Molecular and cellular mechanisms of anthracycline cardiotoxicity
Chen, B., Peng, X., Pentassuglia, L., Lim, C. C., & Sawyer, D. B. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0005-5 · Cited by 172
Self-citationImpact of adjuvant therapy on quality of life in women with node-positive operable breast cancer
International Breast Cancer Study Group, Hürny, C., Bernhard, J., Castiglione-Gertsch, M., Coates, A. S., Peterson, H. F., Gelber, R. D., Forbes, J. F., Rudenstam, C.-M., Simoncini, E., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90936-8 · Cited by 171
Swain, S. M., & Vici, P. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0498-7 · Cited by 155
Tang, Y. (2008) · 北京周报:英文版 · Cited by 143
Chemical, Biological and Clinical Aspects of Dexrazoxane and Other Bisdioxopiperazines
Hasinoff, B. B., Hellmann, K., Herman, E., & Ferrans, V. J. (1998) · Current Medicinal Chemistry · doi:10.2174/0929867305666220314194045 · Cited by 141
Self-citationNoninvasive Evaluation of Late Anthracycline Cardiac Toxicity in Childhood Cancer Survivors
Hudson, M. M., Rai, S. N., Núnêz, C., Merchant, T. E., Marina, N. M., Zalamea, N. N., Cox, C. L., Phipps, S., Pompeu, R. G., & Rosenthal, D. N. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7451 · Cited by 124
Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?
Hasinoff, B. B., & Herman, E. H. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0023-3 · Cited by 123
Self-citationGreen, D. M., Hyland, A. J., Chung, C. S., Zevon, M. A., & Hall, B. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3207 · Cited by 121
Role of mtDNA lesions in anthracycline cardiotoxicity
Lebrecht, D., & Walker, U. A. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0009-1 · Cited by 115
Pathophysiology and diagnosis of cancer drug induced cardiomyopathy
Zuppinger, C., Timolati, F., & Suter, T. M. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0016-2 · Cited by 113
Anthracycline cardiotoxicity in long-term survivors of childhood cancer
Scully, R. E., & Lipshultz, S. E. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0006-4 · Cited by 109
Self-citationPreclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity.
Herman, E., & Ferrans, V. J. (1998) · PubMed · Cited by 104
Self-citationHerman, E. H. (1985) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(85)90284-4 · Cited by 99
Self-citationDefective One- or Two-electron Reduction of the Anticancer Anthracycline Epirubicin in Human Heart
Salvatorelli, E., Guarnieri, S., Menna, P., Liberi, G., Calafiore, A. M., Mariggiò, M. A., Mordente, A., Gianni, L., & Minotti, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508343200 · Cited by 93
Self-citationMeissner, K., Heydrich, B., Jedlitschky, G., zu Schwabedissen, H. E. M., Mosyagin, I. G., Dazert, P., Eckel, L., Vogelgesang, S., Warzok, R., Böhm, M., et al. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6750.2005 · Cited by 93
Ganz, P. A., Hussey, M. A., Moinpour, C. M., Unger, J. M., Hutchins, L. F., Dakhil, S. R., Giguere, J. K., Goodwin, J. W., Martino, S., & Albain, K. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8877 · Cited by 85
Cardiovascular Trials in Long-Term Survivors of Childhood Cancer
Lipshultz, S. E., & Colan, S. D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.12.937 · Cited by 85
Self-citationGenotyping the risk of anthracycline-induced cardiotoxicity
Deng, S., & Wojnowski, L. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0024-2 · Cited by 79
Adamcová, M., Šimůnek, T., Mertlíková‐Kaiserová, H., Popelová, O., Štěrba, M., Potáčová, A., Vávrová, J., Maláková, J., & Geršl, V. (2007) · Toxicology · doi:10.1016/j.tox.2007.05.016 · Cited by 62
Cardiac safety of liposomal anthracyclines
Batist, G. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0014-4 · Cited by 62
Nutritional Approaches to Late Toxicities of Adjuvant Chemotherapy in Breast Cancer Survivors
Rock, E. P., & DeMichele, A. M. (2003) · Journal of Nutrition · doi:10.1093/jn/133.11.3785s · Cited by 60
Mitra, M. S., Donthamsetty, S., White, B., Latendresse, J. R., & Mehendale, H. M. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.07.018 · Cited by 52
New iron chelators in anthracycline-induced cardiotoxicity
Mertlíková‐Kaiserová, H., Šimůnek, T., Štěrba, M., den Hartog, G. J. M., Schröterová, L., Popelová, O., Geršl, V., Kvasničková, E., & Bast, A. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0020-6 · Cited by 47
Monitoring of Anthracycline-Induced Cardiotoxicity
Jannazzo, A., Hoffman, J. L., & Lutz, M. R. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k359 · Cited by 46
Myocardial Strain Analysis in a Doxorubicin-Induced Cardiomyopathy Model
Piegari, E., Salvo, G. D., Castaldi, B., Vitelli, M. R., Rodolico, G., Golino, P., Calabrò, R., Rossi, F., & Berrino, L. (2007) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2007.08.002 · Cited by 34
Exercise rehabilitation of pediatric patients with cardiovascular disease
Miller, T. L., Horgan, S., & Lipshultz, S. E. (2005) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2004.12.002 · Cited by 32
Self-citationStolen, K. Q., Kemppainen, J., Kalliokoski, K. K., Hällsten, K., Luotolahti, M., Karanko, H., Lehikoinen, P., Viljanen, T., Salo, T., Airaksinen, J. K. E., et al. (2004) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2003.08.009 · Cited by 32
Animal models of anthracycline cardiotoxicity: Basic mechanisms and cardioprotective activity
Herman, E. H., & Ferrans, V. J. (1997) · Progress in Pediatric Cardiology · doi:10.1016/s1058-9813(98)00002-2 · Cited by 30
Self-citationAntioxidant defense against anthracycline cardiotoxicity by metallothionein
Kang, Y. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0007-3 · Cited by 28
Iron signaling and oxidant damage
Kalyanaraman, B. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0025-1 · Cited by 23
Lipshultz, S. E., Cohen, H. J., Colan, S. D., & Herman, E. H. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600800231 · Cited by 16
Self-citationHeart failure in childhood cancer survivors
Lipshultz, S. E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0818 · Cited by 15
Self-citationMcHowat, J., Swift, L., Crown, K. N., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069419 · Cited by 13
Endothelins: a Possible Mechanism of Cytostatics-induced Cardiomyopathy
Zsáry, A., SZÛCS, S., Keltai, K., Schneider, T. J., Rosta, A., Sármán, P., Fenyvesi, T., & Karádi, I. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001593607 · Cited by 7
Cited by
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013777 · Cited by 1,733
The Principles of Engineering Immune Cells to Treat Cancer
Lim, W. A., & June, C. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.016 · Cited by 1,080
Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111708 · Cited by 909
Bozkurt, B., Colvin, M., Cook, J., Cooper, L. T., Deswal, A., Fonarow, G. C., Francis, G. S., Lenihan, D., Lewis, E. F., McNamara, D. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000455 · Cited by 891
Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
Albini, A., Pennesi, G., Donatelli, F., Cammarota, R., De Flora, S., & Noonan, D. M. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp440 · Cited by 839
Metadata
- Authors
- Gianni, L., Herman, E. H., Lipshultz, S. E., Minotti, G., Sarvazyan, N., & Sawyer, D. B.
- Venue
- Journal of Clinical Oncology
- Published
- 2008-08-01
- Volume
- 26
- Issue
- 22
- Pages
- 3777-3784
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2164159671
- Cited by
- 454
- References
- 97
- FWCI
- 22.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.